Click to View in Browser
Friday, September 22, 2017
State funding changes in spotlight in Republican healthcare bill
WASHINGTON (Reuters) - Republican leaders sought to nail down the final votes needed to pass what U.S. Vice President Mike Pence on Thursday called their "last best chance" to repeal Obamacare while a new analysis underscored how Democratic-leaning states stand to lose large amounts of federal funding under the legislation.
U.S. safety board says train crash engineers had undiagnosed sleep disorder
WASHINGTON (Reuters) - The engineers in two New York City area commuter train crashes suffered from sleep apnea that had not been diagnosed, the U.S. National Transportation Safety Board said on Thursday.
BYU lifts decades-long ban on caffeinated soft drink sales
(Reuters) - Brigham Young University has ended a 60-year ban on the sale of caffeinated soft drinks at its flagship campus in Provo, Utah, the Mormon Church-owned school said on Thursday.
Roche receives EU approval for Gazyvaro, European approval for Actemra
ZURICH (Reuters) - Roche said it has received European approval for its Actemra medication in giant cell arteritis (GCA), the Swiss drugmaker said on Friday.
Versartis growth hormone drug fails key study, shares sink
(Reuters) - Versartis Inc said its experimental drug for the treatment of growth hormone deficiency in children did not meet the main goal of a late-stage study, sending its shares tanking 85 percent.
Many drug companies fail to conduct timely safety checks on medicines after FDA approval
(Reuters Health) - In the rush to approve new medicines, the U.S. Food and Drug Administration often requires drug companies to study possible side effects and alternative doses for medicines once they hit the broader market.
A daily half hour's exercise could prevent 1 in 12 early deaths, study shows
LONDON, Sept 22 (Reuters) - People who exercise five days a week for 30 minutes significantly reduce their risk of dying early and of developing heart disease, even if a sports club or gym is not an option, according to a new international study.
Cans of 'Death Wish' coffee recalled over possible toxin
NEW YORK (Reuters) - Death Wish Coffee Co, a New York coffee maker that sells what it says is the "World's Strongest Coffee," is recalling cans of its Nitro Cold Brew because of the risk that some could contain the deadly toxin botulin.
Exclusive: Africa to get state-of-art HIV drugs for $75 a year
LONDON (Reuters) - Makers of generic AIDS drugs will start churning out millions of pills for Africa containing a state-of-the-art medicine widely used in rich countries, after securing a multi-million dollar guarantee that caps prices at just $75 per patient a year.
Dozens of alcohol-flavored tobacco products may lure teens
(Reuters Health) - Nearly 50 alcohol-flavored tobacco product lines are marketed by more than 400 tobacco brands in the United States and these products may especially attract teens, luring them into tobacco addiction, according to a new study.
Related Video
Starbucks UK to upcycle store waste into furniture
Australian solar team prepares for global race
A quick-fix on the day's news delivered when you want it. Register Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today
» » MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters
Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book.
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter Friend us on Facebook